Asterias Biotherapeutics Inc
(AST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,266 | 19,800 | 11,183 | 3,076 | 2,171 |
| Marketable Securities | 8,329 | 15,269 | 17,006 | 14,374 | 32,052 |
| Receivables | N/A | N/A | 567 | 496 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 15,568 |
| TOTAL | $22,716 | $36,990 | $29,789 | $18,384 | $50,132 |
| Non-Current Assets | |||||
| PPE Net | 4,543 | 5,475 | 5,756 | 1,045 | 1,461 |
| Investments And Advances | 0 | 0 | 416 | 416 | 416 |
| Intangibles | 15,444 | 18,130 | 20,816 | 23,502 | 28,292 |
| Other Non-Current Assets | 389 | 415 | 457 | 767 | 55 |
| TOTAL | $20,376 | $24,020 | $27,445 | $25,730 | $30,222 |
| Total Assets | $43,092 | $61,010 | $57,234 | $44,114 | $80,354 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 401 | 1,076 | 747 | 737 | 567 |
| Accrued Expenses | 2,557 | 2,495 | 1,183 | 430 | 96 |
| Other current liabilities | 0 | 288 | 530 | 615 | 17,633 |
| TOTAL | $3,521 | $6,535 | $4,980 | $6,497 | $18,296 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 2,185 | 2,513 | 2 | N/A |
| Other Non-Current Liabilities | 5,698 | 12,161 | 4,400 | 378 | 0 |
| TOTAL | $6,028 | $12,447 | $7,155 | $4,986 | $8,278 |
| Total Liabilities | $9,549 | $18,982 | $12,135 | $11,483 | $26,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,201 | 48,953 | 38,352 | 32,312 | 30,499 |
| Common Shares | 5 | 5 | 4 | 3 | 3 |
| Retained earnings | -112,100 | -83,728 | -48,239 | -33,236 | -23,139 |
| Other shareholders' equity | -6,498 | -1,078 | 434 | -503 | -2,935 |
| TOTAL | $33,543 | $42,028 | $45,099 | $32,631 | $53,781 |
| Total Liabilities And Equity | $43,092 | $61,010 | $57,234 | $44,114 | $80,354 |